2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Sezary Syndrome
2
Primary Myelofibrosis
2
Neuroblastoma
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Iron Overload
2
Hodgkin Disease
2
Congenital Abnormalities
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Testicular Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
Cytarabine
14
fludarabine
13
venetoclax
11
Imatinib Mesylate
9
Cyclophosphamide
8
Azacitidine
8
fludarabine phosphate
7
Busulfan
7
Whole-Body Irradiation
6
Tacrolimus
6
Mycophenolic Acid
6
thymoglobulin
4
ponatinib
4
nilotinib
4
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
asciminib
3
aldesleukin
3
Melphalan
3
Interleukin-2
3
Idarubicin
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Decitabine
3
Bone Marrow Transplantation
3
Antilymphocyte Serum
3
zosuquidar trihydrochloride
2
gilteritinib
2
enasidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Myeloid
×
Deferasirox
×
Clear all
NCT03659084
2018-09-06
GREFFE
Hospices Civils de Lyon
Unknown
150 enrolled